Amino acid/haplotype/group | Inflammatory polyarthritis (IP) | Rheumatoid arthritis (RA) | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
All-cause mortality | Cardiovascular mortality | All-cause mortality | Cardiovascular mortality | |||||||||
Hazard ratio (95% CI) | p value | n | Hazard ratio (95% CI) | p value | n | Hazard ratio (95% CI) | p value | n | Hazard ratio (95% CI) | p value | n | |
Valine 11 | 1.16 (1.03, 1.30) | 0.015 | 643 (2514) | 1.10 (0.93, 1.30) | 0.255 | 343 (2514) | 1.10 (0.95, 1.28) | 0.217 | 367 (1160) | 0.96 (0.77, 1.19) | 0.699 | 189 (1160) |
Serine 11 | 0.83 (0.75, 0.94) | 0.003 | 643 (2514) | 0.82 (0.70, 0.96) | 0.016 | 343 (2514) | 0.83 (0.71, 0.97) | 0.022 | 367 (1160) | 0.86 (0.69, 1.07) | 0.177 | 189 (1160) |
Difference | 1.26 (1.09, 1.45) | 0.001 | 1.23 (1.01, 1.49) | 0.038 | 1.22 (1.01, 1.47) | 0.035 | 1.08 (0.83, 1.41) | 0.559 | ||||
VKA haplotype | 1.15 (0.99, 1.34) | 0.073 | 579 (2328) | 1.16 (0.94, 1.43) | 0.158 | 310 (2328) | 1.14 (0.94, 1.38) | 0.190 | 333 (1078) | 1.05 (0.79, 1.40) | 0.715 | 167 (1078) |
SEA haplotype | 0.76 (0.59, 0.96) | 0.024 | 579 (2328) | 0.67 (0.47, 0.94) | 0.023 | 310 (2328) | 0.63 (0.44, 0.89) | 0.009 | 333 (1078) | 0.49 (0.28, 0.85) | 0.011 | 167 (1078) |
Difference | 1.46 (1.11, 1.93) | 0.007 | 1.67 (1.13, 2.48) | 0.010 | 1.75 (1.19, 2.58) | 0.005 | 2.09 (1.14, 3.84) | 0.018 | ||||
Group 1 | 1.11 (0.98, 1.26) | 0.101 | 579 (2328) | 1.10 (0.93, 1.31) | 0.266 | 319 (2328) | 1.04 (0.89, 1.23) | 0.622 | 333 (1078) | 0.96 (0.76, 1.21) | 0.720 | 167 (1078) |
Group 4 | 0.78 (0.67, 0.90) | 0.001 | 579 (2328) | 0.73 (0.60, 0.89) | 0.002 | 319 (2328) | 0.76 (0.63, 0.93) | 0.007 | 333 (1078) | 0.72 (0.55, 0.96) | 0.025 | 167 (1078) |
Difference | 1.31 (1.11, 1.54) | 0.001 | 1.37 (1.09, 1.72) | 0.007 | 1.27 (1.02, 1.58) | 0.034 | 1.25 (0.91, 1.73) | 0.168 |